Compared to traditional insulin therapy, the insulin pump allows you to receive a precise and constant supply of insulin over time, emulating the functionality of the pancreas; in addition, the basal rate of insulin administration can be adjusted according to the patient’s needs and psychophysical state.
In particular, they benefit more: subjects with frequent hypoglycemia and very sensitive to insulin, as the insulin pump allows the release of small amounts of insulin. People struggling to maintain proper glycemic compensation.
Being very discreet, it can be worn under clothes without being noticed, leaving the diabetic patient the freedom to live their daily life without limits and without giving up.
The insulin pump is not a limitation, on the contrary, it can be a valid aid to better manage diabetes in everyday life, reconciling work, sports, medical visits and travel. A Sydney City Cardiologist can provide quality care.
Do you have to leave for a trip? No problem, even in this case you can take your insulin pump with you, whatever the means of transport.
Suffering from type 2 diabetes means having to constantly monitor blood glucose levels and regulate them through insulin injections that are repeated several times a day, making it difficult and difficult to manage patients’ lives.
To help those suffering from type 2 diabetes, a new pen has now arrived with twice as many insulin units available as it reduces the number of syringes that need to be managed every day, simplifying everyday life.
The new insulin lispro is the U200 which has recently arrived is known for its 2 × 1 formula which, as we said, implies twice the concentration compared to the insulins normally used. Thanks to this composition, the force necessary to deliver the drug is also reduced by 53% and its injection is simpler, in other words the 2 × 1 would seem to be the favorite among patients with type 2 diabetes. You can also consult with a Sydney City Cardiologist.
The functionality of this new pen is in allowing patients to constantly monitor blood glucose levels, a problem that is typical among diabetic patients who, due to the lack of ease in using the injections, often do not adequately manage the insulin making the less effective treatment.
Most people with diabetes cannot reach their intended metabolic targets. One of the main causes of this difficulty is connected to the complexity of the daily management of therapy. With this pen, however, the management obstacle would seem outdated, it is enough to inject half the volume to get the usual dose.
This reduces the force necessary to deliver insulin, making the injection softer and simpler. It also halves the number of pens to be managed and brought along.
No Comments